Kadcyla Boosts Survival in Some Women With Early Breast Cancer

FRIDAY, June 28, 20204 (HealthDay news) -- An immunotherapy/chemotherapy combo drug can help early-stage breast cancer patients remain cancer-free following treatment, a new trial shows.

The combo drug, Kadcyla, is already approved to treat...